Cross‐linking by tissue transglutaminase‐2 alters fibrinogen‐directed macrophage proinflammatory activity

Background The blood coagulation factor fibrin(ogen) can modulate inflammation by altering leukocyte activity. Analyses of fibrin(ogen)‐mediated proinflammatory activity have largely focused on leukocyte integrin binding activity revealed by conversion of fibrinogen to a stabilized fibrin polymer by...

Full description

Saved in:
Bibliographic Details
Published inJournal of thrombosis and haemostasis Vol. 20; no. 5; pp. 1182 - 1192
Main Authors Poole, Lauren G., Kopec, Anna K., Flick, Matthew J., Luyendyk, James P.
Format Journal Article
LanguageEnglish
Published England Elsevier Limited 01.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The blood coagulation factor fibrin(ogen) can modulate inflammation by altering leukocyte activity. Analyses of fibrin(ogen)‐mediated proinflammatory activity have largely focused on leukocyte integrin binding activity revealed by conversion of fibrinogen to a stabilized fibrin polymer by blood coagulation enzymes. In addition to coagulation enzymes, fibrinogen is a substrate for tissue transglutaminase‐2 (TG2), a widely expressed enzyme that produces unique fibrinogen Aα‐γ chain cross‐linked products. Objectives We tested the hypothesis that TG2 dependent cross‐linking alters the proinflammatory activity of surface‐adhered fibrinogen. Methods Mouse bone marrow‐derived macrophages (BMDMs) were cultured on tissue culture plates coated with fibrinogen or TG2‐cross‐linked fibrinogen (10 µg/ml) and then stimulated with lipopolysaccharide (LPS, 1 ng/ml) or vehicle for various times. Results In the absence of LPS stimulation, TG2‐cross‐linked fibrin(ogen) enhanced inflammatory gene induction (e.g., Tnfα) compared with unmodified fibrinogen. LPS stimulation induced mitogen‐activated protein kinase phosphorylation, IκBα degradation, and expression of proinflammatory cytokines (e.g., tumor necrosis factor α) within 60 min. This initial cellular activation was unaffected by unmodified or TG2‐cross‐linked fibrinogen. In contrast, LPS induction of interleukin‐10 mRNA and protein and STAT3 phosphorylation was selectively attenuated by TG2‐cross‐linked fibrinogen, which was associated with enhanced proinflammatory cytokine secretion by LPS‐stimulated BMDMs at later time points (6 and 24 h). Conclusions The results indicate that atypical cross‐linking by TG2 imparts unique proinflammatory activity to surface‐adhered fibrinogen. The results suggest a novel coagulation‐independent mechanism controlling fibrinogen‐directed macrophage activation.
Bibliography:Funding information
This work was supported by grants from the National Institutes of Health (R01ES017537 and R01DK120289 to J. P. L. and K99DK129710 and F32DK121423 to L. G. P.), and R01DK112778 (to M. J. F.), as well as additional support from the US Department of Agriculture (USDA) National Institute of Food and Agriculture (to J. P. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, or the USDA.
Manuscript Handled by: Patricia Liaw
Final decision: Patricia Liaw, 07 February 2022
Author Contributions
L. G. Poole contributed to all aspects of this work, including conception and design of experiments, acquisition, analysis, and interpretation of data, and drafting of the manuscript. A. K. Kopec designed and performed experiments, and contributed to data acquisition, analysis, and interpretation. M. J. Flick and J. P. Luyendyk interpreted data and contributed to the drafting of the manuscript. All authors read and approved the final version of the manuscript for submission to Journal of Thrombosis and Haemostasis.
ISSN:1538-7933
1538-7836
1538-7836
DOI:10.1111/jth.15670